Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Acute stage" patented technology

The Acute Stage. Also called the inflammatory stage, the acute stage occurs at the time of the injury, and usually continues for up to almost a week. During the acute stage, symptoms of inflammation, which include redness, swelling, pain at rest and loss of function will likely occur.

Method and system for pain state discrimination based on specific neural circuit activity patterns

PendingCN122320456AAchieve precise targetingRealize functionPain.statusAcute stage
A method and system for differentiating acute and chronic pain based on the functional state of specific neural circuits is proposed. This method utilizes in vivo two-photon / endoscopic calcium imaging and ex vivo brain slice patch-clamp techniques to longitudinally monitor the activity dynamics of neurons in the DRN and ZI brain regions during the acute and chronic phases of a neuropathic pain model. By extracting and analyzing calcium and electrophysiological signal parameter sets, distinguishing criteria are established: if the activity of 5-HTergic neurons in the DRN is specifically enhanced in the acute phase, the indication is acute pain; if the activity of GABAergic neurons in the ZI is specifically enhanced in the chronic phase, the indication is chronic pain. This invention achieves an objective and precise differentiation of the transition from acute to chronic pain at the level of specific neural circuits, providing a new strategy and tool for pain mechanism research and clinical diagnosis and treatment.
Owner:ANHUI MEDICAL UNIV

Orthopedic postoperative patient physiological data analysis method and system

The invention relates to the technical field of physiological data monitoring, in particular to an orthopedic postoperative patient physiological data analysis method and system.The orthopedic postoperative patient physiological data analysis method comprises the following steps that heart rate blood oxygen and limb activity data are collected, a heart rate fluctuation value, a blood oxygen change value and an activity range are extracted, and a multi-dimensional physiological feature sequence is constructed; and calculating a data change range in the sliding window of each dimension and a frequency change value of adjacent windows. According to the method, fine quantitative analysis of heart rate fluctuation, oxyhemoglobin saturation and limb movement amplitude is achieved by dynamically adjusting data time span and calculating indexes in a segmented mode, change characteristics of different recovery stages are adapted, data cleaning accuracy is improved through high-density region statistics and noise elimination, scientific induction of dynamic characteristics is ensured, and the method has good application prospects. In combination with feature extraction and trend analysis of an acute period, a functional reconstruction period and a stable period, comprehensive evaluation of inter-stage features is formed, and based on an offset rate, a prediction deviation value and abnormal signal trajectory labeling, the anomaly identification and real-time tracking capability is enhanced.
Owner:NANTONG UNIV

Use of biomarkers to discriminate between acute and chronic phases of brucellosis

ActiveCN120971742BBiological testingBiologic markerBrucellosis
The application relates to the technical field of markers, in particular to application of biomarkers for identifying acute and chronic stages of brucellosis. A series of biomarkers related to acute and chronic stages of brucellosis are screened and found, and the biomarkers are significantly different between patients with acute and chronic brucellosis. The biomarkers can be used to realize acute and chronic staging of brucellosis, and have high sensitivity and specificity and good diagnostic efficiency. The application provides a new molecular diagnostic tool for acute and chronic staging of brucellosis, solves the problems of low specificity of existing serological detection and incapability of accurately judging clinical stages, and has a wide application prospect.
Owner:ICDC CHINA CDC

A bilayer core-shell nanoparticle composite thermosensitive gel for postoperative analgesia, its preparation method and application

PendingCN122297403AImplement sequential releaseImprove complianceAnalgesia postoperativePostoperative Pains
This invention relates to the fields of biomedicine and nanomaterials technology, and provides a bilayer core-shell nanoparticle composite thermosensitive gel for postoperative analgesia, its preparation method, and its applications. The bilayer core-shell nanoparticles comprise: a core of PLGA nanoparticles loaded with magnesium, and a shell of a lipid bilayer loaded with bupivacaine. The composite thermosensitive gel is made by uniformly dispersing the bilayer core-shell nanoparticles in a thermosensitive gel material. By constructing a structure with a lipid shell loaded with bupivacaine and a PLGA core loaded with magnesium, and combining it with a thermosensitive gel, this invention achieves rapid release of bupivacaine for acute postoperative analgesia, and sustained slow release of magnesium ions for long-term anti-inflammatory and repairing effects. This perfectly meets the temporal requirements of postoperative pain management and has broad clinical application prospects.
Owner:CHINESE ACADEMY OF MEDICAL SCIENCES FUWAI HOSPITAL SHENZHEN HOSPITAL (SHENZHEN SUN YAT-SEN CARDIOVASCULAR HOSPITAL)

Blood pressure dynamic measurement frequency adjusting method and system based on patient condition staging

The invention relates to the field of medical monitoring, in particular to a blood pressure dynamic measurement frequency adjusting method and system based on patient condition staging, and the method comprises the steps: obtaining clinical data of a patient, judging that the patient is in an acute stage, a subacute stage or a stable stage according to a preset standard, matching a corresponding initial blood pressure measurement frequency according to a staging result, and executing monitoring. Blood pressure data are recorded and analyzed in real time, if abnormal changes of the blood pressure are found, the measurement frequency is dynamically increased according to the abnormal severity degree, an acousto-optic-electric alarm is triggered to prompt medical staff, meanwhile, the system regularly judges the disease stage of a patient again, if the stage changes, the monitoring frequency is automatically adjusted according to the new stage, and data in the whole process are stored. Closed-loop management integrating staging judgment, dynamic monitoring, intelligent alarm and self-adaptive adjustment is formed, and therefore optimal configuration of monitoring resources and timely intervention of patient risks are achieved.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

A method and system for predicting the burden risk of a family caregiver of a minor stroke patient

The application discloses a kind of small stroke patient family caregiver burden risk prediction method and system, comprising: constructing research cohort and collecting the baseline clinical data of patient acute phase and the baseline information of family caregiver;Through statistical analysis, the independent correlation of the prediction variable of caregiver medium-severe burden is screened out;Based on the variable and its regression coefficient screened out, a nomogram prediction model is constructed, the score of each variable value is converted, the individual risk probability is predicted by accumulating total score;And ROC curve and Bootstrap resampling method are used to verify the model.The system includes data input, prediction calculation and result output module, and can be integrated into clinical information system.The application can realize individualization, quantification early warning of future burden risk of family caregiver of small stroke patient in acute phase, provide key decision support for implementing precise nursing intervention, effectively improve nursing resource efficiency and family care quality.
Owner:SHANGHAI TENTH PEOPLES HOSPITAL

System for evaluating person suffering from covid-19, method for evaluating person suffering from covid-19, and computer program

PCT designated stageWO2026100590A1Biological testingBlood concentrationQuinolizine
[Problem] To suggest the possibility of olfactory / gustatory abnormality (impairment) by means of a numerical value based on the metabolism of tryptophan in the kynurenine pathway. [Solution] A system 1 for evaluating a person suffering from COVID-19 comprises: an acquisition means 10 for acquiring a numerical value based on the metabolism of tryptophan in the kynurenine pathway obtained by analyzing serum S during an acute phase of COVID-19 in a person suffering from COVID-19; and an evaluation means 30 that indicates the possibility of olfactory / gustatory abnormality (impairment) in the person suffering from COVID-19 on the basis of the numerical value (for example, a KTR value or a blood concentration value for quinolinic acid).
Owner:KANAGAWA PREFECTURAL HOSPITAL ORG